Table 1—

Physiological outcomes

GroupAssessments
Significance of MANCOVA*
Baseline6 monthsIndividual (6 months)Overall (6 months)
HbA1c and serum lipids0.019
 HbA1c (%)MLP (Tx)7.43 ± 1.307.07 ± 1.110.000
UC (control)7.40 ± 1.487.38 ± 1.33
 Triglycerides (mg/dl)MLP (Tx)202.38 ± 149.06176.82 ± 113.980.982
UC (control)171.59 ± 110.56157.93 ± 88.82
 Total cholesterol (mg/dl)MLP (Tx)191.57 ± 37.84187.61 ± 35.600.963
UC (control)181.77 ± 36.69180.72 ± 39.73
 HDL cholesterol (mg/dl)MLP (Tx)43.12 ± 11.0643.49 ± 10.140.823
UC (control)44.05 ± 12.6943.46 ± 11.99
 LDL cholesterol (mg/dl)MLP (Tx)118.64 ± 31.97118.43 ± 30.640.987
UC (control)113.33 ± 30.78114.22 ± 32.86
BMI/waist-to-hip ratio0.015
 BMI (kg/m2)MLP (Tx)35.34 ± 7.9334.97 ± 7.850.009
UC (control)34.87 ± 8.2035.07 ± 8.48
 Waist-to-hip ratioMLP (Tx)0.91 ± .070.90 ± .070.318
UC (control)0.90 ± .080.88 ± .08
Quality of life0.021
 PAID social summary (score)MLP (Tx)12.96 ± 5.2211.63 ± 4.330.871
UC (control)12.55 ± 5.0511.31 ± 4.83
 PAID self-care summary scoreMLP (Tx)19.14 ± 5.5315.04 ± 4.680.005
UC (control)18.03 ± 5.8015.94 ± 5.33
 MOS-12 physical health (score)MLP (Tx)40.28 ± 10.6040.68 ± 11.340.601
UC (control)40.46 ± 12.4141.32 ± 12.62
 MOS-12 mental health (score)MLP (Tx)46.60 ± 9.3046.67 ± 9.710.438
UC (control)46.99 ± 9.2746.13 ± 9.45
Blood pressure0.069
 Average systolic (mmHg)MLP (Tx)136.06 ± 13.91134.21 ± 14.300.483
UC (control)134.01 ± 14.17131.83 ± 14.63
 Average diastolic (mmHg)MLP (Tx)79.29 ± 9.4977.15 ± 8.770.204
UC (control)77.38 ± 9.2076.94 ± 8.33
Plasma fatty acids0.059
 18:2 (n-6) (relative weight percent)MLP (Tx)23.88 ± 4.8325.99 ± 3.910.573
UC (control)25.20 ± 5.8726.80 ± 5.35
 20:5 (n-3) (relative weight percent)MLP (Tx)0.47 ± .290.68 ± .400.022
UC (control)0.51 ± .370.56 ± .26
 22:6 (n-3) (relative weight percent)MLP (Tx)0.97 ± .381.14 ± .470.864
UC (control)1.00 ± .411.13 ± .47
Flexibility0.095
 Sit-and-reach (percentile)MLP (Tx)31.91 ± 23.4734.21 ± 27.510.093
UC (control)32.30 ± 25.7329.66 ± 26.80
 Range of motion (percentile)MLP (Tx)14.01 ± 23.1014.23 ± 24.170.136
UC (control)11.16 ± 22.109.45 ± 19.88
  • Data are means ± SD.

  • *

    * Significance of two-tailed MANCOVA comparing MLP (treatment) and UC (control) nonadjusted follow-up scores, covarying out the effects of baseline scores and social desirability. Tx, treatment.